Comparison of neoeriocitrin and naringin on proliferation and osteogenic differentiation in MC3T3-E1.

@article{Li2011ComparisonON,
  title={Comparison of neoeriocitrin and naringin on proliferation and osteogenic differentiation in MC3T3-E1.},
  author={Lina Li and Zhen Zeng and Guoping Cai},
  journal={Phytomedicine : international journal of phytotherapy and phytopharmacology},
  year={2011},
  volume={18 11},
  pages={
          985-9
        }
}
Naringin is considered the main effective compound of Drynaria Rhizome, which is used commonly in the treatment of osteoporosis in traditional Chinese medicine. However, we found neoeriocitrin, a new compound isolated from Drynaria Rhizome, showed a better activity than naringin on proliferation and osteogenic differentiation in MC3T3-E1. Both neoeriocitrin and naringin exhibited the best effect on proliferation and osteogenic differentiation at concentration of 2μg/ml. Neoeriocitrin more… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Effects of eleven flavonoids from the osteoprotective fraction of Drynaria fortunei ( KUNZE ) J . SM . on osteoblastic proliferation using an osteoblast - like cell line

  • C. H. Wong, C. Y. Cheng
  • Chem . Pharm . Bull . ( Tokyo )
  • 2005
1 Excerpt

A review of clinical trials of therapies for osteoporosis using fracture as an end point

  • R. S. Bockman
  • J . Clin . Densitom .
  • 1999
1 Excerpt

Osf 2 / Cbfa 1 : a transcriptional activator of osteoblast differentiation

  • P. ucy, R. Zhang, V. Geoffroy, A. L. Ridall, G. Karsenty
  • 1997

Similar Papers

Loading similar papers…